South Korean medical aesthetics manufacturer Humedix saw its Q1 2026 operating profit drop 22% year-on-year to KRW 8.9 billion, hit by a sharp decline in its core filler business and a halving of export revenue. The results signal mounting pressure on the company's aesthetic portfolio and heavy reliance on the Chinese market, a key concern for overseas distributors and clinic buyers monitoring supply stability.
Filler and toxin sales collapse
Humedix reported Q1 filler sales of KRW 8.2 billion, down 43.3% from KRW 14.5 billion a year earlier. Sales of its botulinum toxin brand 'Liztox' also fell 16.3% to KRW 2.8 billion. The combined slump in its two flagship aesthetic categories drove the overall profit decline, despite total revenue holding nearly flat at KRW 40.5 billion.
Export revenue halves on China dependency
Export revenue in Q1 totaled KRW 4.7 billion, a 50.1% drop from KRW 9.4 billion in the same period last year. China accounted for 68% of Humedix's export sales, underscoring the company's vulnerability to regulatory or demand shifts in that single market. For overseas buyers, this concentration raises questions about alternative supply routes and product availability.
Eye drop CMO and cosmetics provide partial buffer
Humedix's contract manufacturing (CMO) business for eye drops surged 85.2% to KRW 5 billion, helping offset some of the aesthetic losses. Its cosmetics segment also grew 22.5% to KRW 1.9 billion. However, these segments remain small relative to the core filler and toxin lines.
What buyers should watch
Humedix is actively expanding its aesthetic portfolio through exclusive domestic distribution deals for external products such as 'Estefil', 'Elravie Lituo', and 'Lidbooster', aiming to strengthen its skin booster lineup. For overseas importers and clinic buyers, this signals a strategic pivot toward a broader product mix, which may eventually offer new sourcing opportunities. However, near-term supply of fillers and toxins from Humedix could remain constrained as the company navigates its export downturn.
Source: Read the original report | Published: June 04, 2026